Gary Phillips
Chairman chez NANOBIOTIX
Fortune : 48 435 $ au 31/03/2024
Profil
Gary M.
Phillips currently works at OrphoMed, Inc., as President & Chief Executive Officer from 2018, Nanobiotix SA, as Chairman-Supervisory Board from 2021, Aldeyra Therapeutics, Inc., as Independent Director from 2009, Rheon Medical SA, as Director, Helio Vision, Inc., as Director, and Anaveon AG, as Chief Business Officer.
Dr. Phillips also formerly worked at Envisia Therapeutics, Inc., as Executive Chairman, Inotek Pharmaceuticals Corp., as Director, Zyla Life Sciences LLC, as Independent Director from 2019 to 2020, Novartis Pharmaceuticals Corp., as Executive Director-Strategic Planning from 2000 to 2002, Bausch & Lomb, Inc., as President-U.S.
Surgical & Pharmaceuticals from 2002 to 2008, Mallinckrodt Plc, as Chief Strategy Officer & Executive Vice President, Towers Perrin, Inc., as Managing Consultant from 1997 to 1999, Forum Mondial de L'Economie, as Head-Global Health & Healthcare from 2012 to 2013, Mallinckrodt Brand Pharmaceuticals LLC, as Chief Strategy Officer & Executive Vice President from 2013 to 2018, Reckitt Benckiser Pharmaceuticals, Inc., as President from 2011 to 2012, and Towers Watson & Co., as Managing Consultant.
Dr. Phillips received his Masters Business Admin degree in 1991 from The Wharton School of the University of Pennsylvania, doctorate degree in 1992 from Perelman School of Medicine, and undergraduate degree in 1987 from The College of Arts & Sciences.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 07/09/2023 | 14 812 ( 0,03% ) | 48 435 $ | 31/03/2024 |
Postes actifs de Gary Phillips
| Sociétés | Poste | Début |
|---|---|---|
| ALDEYRA THERAPEUTICS, INC. | Director/Board Member | 01/05/2009 |
| NANOBIOTIX | Chairman | 25/05/2021 |
Helio Vision, Inc.
 Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA. | Director/Board Member | - |
OrphoMed, Inc.
 OrphoMed, Inc. Pharmaceuticals: MajorHealth Technology OrphoMed, Inc. develops and manufactures pharmaceutical products. The company was founded Pankaj Jay Pasricha and Frank Steinberg and is headquartered in Mill Valley, CA. | Chief Executive Officer | 23/04/2018 |
Rheon Medical SA
 Rheon Medical SA Medical SpecialtiesHealth Technology Rheon Medical SA develops adjustable glaucoma drainage devices. The firm manufactures eyeWatch, a drainage device for the treatment of glaucoma. It also offers control unit, an instrument that measures and adjusts the eyeWatch's functional position. The company was founded by Nikolaos Stergiopulos and is headquartered in Lausanne, Switzerland. | Director/Board Member | - |
Anaveon AG
 Anaveon AG BiotechnologyHealth Technology Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland. | Corporate Officer/Principal | - |
Anciens postes connus de Gary Phillips
| Sociétés | Poste | Fin |
|---|---|---|
| ZYLA LIFE SCIENCES | Director/Board Member | 20/05/2020 |
Mallinckrodt Brand Pharmaceuticals LLC
 Mallinckrodt Brand Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Mallinckrodt Brand Pharmaceuticals, Inc. engages in the manufacture of pharmaceutical and health products. The company was founded on September 23, 2015 and is headquartered in Hazelwood, MO. | Corporate Officer/Principal | 01/03/2018 |
Forum Mondial de L'Economie
 Forum Mondial de L'Economie Miscellaneous Commercial ServicesCommercial Services Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland. | Corporate Officer/Principal | 01/09/2013 |
| ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Gary Phillips
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Perelman School of Medicine | Doctorate Degree |
| The College of Arts & Sciences | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ALDEYRA THERAPEUTICS, INC. | Health Technology |
| MALLINCKRODT PLC | Health Technology |
| NANOBIOTIX | Health Technology |
| Entreprise privées | 14 |
|---|---|
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Health Technology |
Inotek Pharmaceuticals Corp.
 Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | Health Technology |
Zyla Life Sciences LLC
 Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Zyla Life Sciences is a commercial-stage company, which focuses on developing, manufacturing and commercializing innovative treatments for pain. It is focused on bringing non-narcotic products and abuse-discouraging formulations of opioids to patients and healthcare providers. The company plans to continue to grow revenue of its seven commercial products, which includes Sprix nasal spray, Vivlodex, Zorvolex, Tivorbex, Indocin suppositories, Indocin oral suspension and oxaydo tablets, and explore business development opportunities. Zyla Life Sciences was founded in August 2013 and is headquartered in Wayne, PA. | Health Technology |
Towers Perrin, Inc.
 Towers Perrin, Inc. Miscellaneous Commercial ServicesCommercial Services Towers Perrin, Inc. provides management consulting services. It offers actuarial consulting, executive compensation, financial modeling, reinsurance, health, and welfare consulting services. The company offers solutions to client issues in the areas of human resource strategy, design, and management. Towers Perrin was founded in 1934 and is headquartered in Stamford, CT. | Commercial Services |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Forum Mondial de L'Economie
Forum Mondial de L'Economie Miscellaneous Commercial ServicesCommercial Services Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland. | Commercial Services |
Mallinckrodt Brand Pharmaceuticals LLC
Mallinckrodt Brand Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Mallinckrodt Brand Pharmaceuticals, Inc. engages in the manufacture of pharmaceutical and health products. The company was founded on September 23, 2015 and is headquartered in Hazelwood, MO. | Health Technology |
Reckitt Benckiser Pharmaceuticals, Inc.
 Reckitt Benckiser Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reckitt Benckiser Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. Its products are used to treat chronic relapsing disease of opioid dependence. The company was founded in 2003 and is headquartered in Richmond, VA. | Health Technology |
Towers Watson & Co.
 Towers Watson & Co. Miscellaneous Commercial ServicesCommercial Services Towers Watson & Co. is a global professional services company, which helps organizations to improve performance through people, risk and financial management. The company offers various solutions in four business segments, Benefits, Risk and Financial Services, Talent and Rewards and Exchange Solutions. The Benefits segment offers lines of business which includes Retirement, Health and Group Benefits, Technology & Administration Solutions, and International Consulting. The Risk and Financial Services segment includes three lines of business: Risk Consulting and Software, Investment Consulting & Solutions, and Reinsurance & Insurance Brokerage. The Talent and Rewards segment includes three lines of business: Executive Compensation, Rewards, Talent & Communication, and Data, Surveys and Technology. The Exchange Solutions segment offers one line of business named Extend Health. Towers Watson was founded on January 1, 2010 and is headquartered in Arlington, VA. | Commercial Services |
Rheon Medical SA
Rheon Medical SA Medical SpecialtiesHealth Technology Rheon Medical SA develops adjustable glaucoma drainage devices. The firm manufactures eyeWatch, a drainage device for the treatment of glaucoma. It also offers control unit, an instrument that measures and adjusts the eyeWatch's functional position. The company was founded by Nikolaos Stergiopulos and is headquartered in Lausanne, Switzerland. | Health Technology |
Envisia Therapeutics, Inc.
 Envisia Therapeutics, Inc. BiotechnologyHealth Technology Envisia Therapeutics, Inc. develops novel ocular therapies. It provides glaucoma drug therapies that include PRINT particle therapeutics to overcome biologic and chemical. The company was founded by 2013 is headquartered in Morrisville, NC. | Health Technology |
OrphoMed, Inc.
OrphoMed, Inc. Pharmaceuticals: MajorHealth Technology OrphoMed, Inc. develops and manufactures pharmaceutical products. The company was founded Pankaj Jay Pasricha and Frank Steinberg and is headquartered in Mill Valley, CA. | Health Technology |
Helio Vision, Inc.
Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA. | Health Technology |
Anaveon AG
Anaveon AG BiotechnologyHealth Technology Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland. | Health Technology |
